UBS Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Buy

January 6, 2014 9:25 AM EST Send to a Friend
Get Alerts IDIX Hot Sheet
Price: $24.50 --0%

Rating Summary:
    2 Buy, 14 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 14 | New: 40
Trade IDIX Now!
Join SI Premium – FREE
UBS upgraded Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) from Neutral to Buy.

For an analyst ratings summary and ratings history on Idenix Pharmaceuticals Inc. click here. For more ratings news on Idenix Pharmaceuticals Inc. click here.

Shares of Idenix Pharmaceuticals Inc. closed at $6.27 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

UBS

Add Your Comment